Regeneron (NASDAQ: REGN) reported Q1 EPS of $9.55, $0.64 worse than the analyst estimate of $10.19. Revenue for the quarter came in at $3.15 billion versus the consensus estimate of $3.22 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.